https://www.asm.org/modules/mod_image_show_gk4/cache/mSphere Direct herogk-is-651.pnglink
https://www.asm.org/modules/mod_image_show_gk4/cache/Microbe Submit Abstract Slidegk-is-651.jpglink
https://www.asm.org/modules/mod_image_show_gk4/cache/Science Advisor Slidegk-is-651.jpglink
https://www.asm.org/modules/mod_image_show_gk4/cache/Amy Chang Bannergk-is-651.jpglink
https://www.asm.org/modules/mod_image_show_gk4/cache/Governance Hero Bannergk-is-651.jpglink
0 1 2 3 4
Progress bar
09-12-2016mSphere Direct
09-12-2016Science Advisor
09-12-2016Amy Chang
09-12-2016Nominate
Become a member today!
JOIN/RENEW
Submit to an ASM Journal
SUBMIT
Attend ASM Biothreat Meeting
REGISTER

davis roger

 

Roger J. Davis Ph.D. F.R.S. is an Investigator of the Howard Hughes Medical Institute and is the H. Arthur Smith Chair in the Program in Molecular Medicine at the University of Massachusetts Medical School.  He also serves as Editor-in-Chief of the ASM journal Molecular & Cellular Biology.  The goal of research in the Davis laboratory is to understand mechanisms that mediate inflammation.  A primary focus is to understand the function of protein kinase signaling networks that promote inflammation, including the stress-activated MAP kinases.  These signaling pathways respond to the exposure to inflammatory agents (e.g. endotoxin) and mediate multiple biological responses.  The stress-activated MAP kinases are implicated in both innate and adaptive immune response and contribute to the development of inflammation-related diseases, including arthritis, cancer, diabetes, heart disease, and stroke.  The Davis laboratory is exploring the potential use of drugs to manipulate these signaling pathways for the treatment of human disease.


Visit: http://www.hhmi.org/research/investigators/davisrj.html

 

TPL_asm2013_SEARCH

91214